![Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep22551/MediaObjects/41598_2016_Article_BFsrep22551_Fig2_HTML.jpg)
Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports
![Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep22551/MediaObjects/41598_2016_Article_BFsrep22551_Fig1_HTML.jpg)
Prevalence, incidence estimations and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study | Scientific Reports
![Toxoplasma gondii – gegenwärtige Arzneimittel und zukünftige Impfstoffe gegen eine unterschätzte Protozoonose | SpringerLink Toxoplasma gondii – gegenwärtige Arzneimittel und zukünftige Impfstoffe gegen eine unterschätzte Protozoonose | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00108-021-01155-1/MediaObjects/108_2021_1155_Fig2_HTML.png)